We reasoned that by increasing Hevin levels in hippocampal astrocytes, we could abrogate the malfunctioning of aging synapses to ultimately ameliorate cognitive decline observed in AD pathogenesis. The gene discussed is SPARCL1; the disease is Alzheimer disease.